USPTO serial 79253007
DAMAE MEDICAL
Reviewed by CopyMark Law Group
Reg. 6010115Status 707Registered
- Filing date
- Status date
- Registration date
- Mar 17, 2020
- Examiner
- BETTS, MARCYA N
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with DAMAE MEDICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina Campagna
Pina Campagna Carter, DeLuca, and Farrell, LLP576 Broad Hollow Rd.Melville, NY 11747United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for use in medical decision support systems; downloadable computer software employing computer algorithms for medical data analysis in the medical field; downloadable artificial intelligence software for assisting decision-making in the medical field; electronic computer databases in the field of oncology and skin cancer recorded on computer media; downloadable database management software for use in the medical field; downloadable image processing software; downloadable mobile applications for medical data analysis in the medical field; downloadable computer software comprising medical algorithms for controlling medical apparatus; downloadable computer software comprising medical algorithms for medical diagnosis; downloadable computer software for analyzing and quantification of biophysical, morphological, and anatomical parameters [ ; apparatus for capture and image processing, namely, video cameras, and photo cameras; flat panel image display screens; optical amplifiers; lasers not for medical purposes; optical lenses; prisms for optical use; optical reflectors; imaging apparatus for scientific use, namely, optical scanners, and optical coherence tomography machines, namely, a device using image projection technology that focuses light onto biological tissues to create afterimages for the user; microscopes; biology microscopes; electron microscopes; operating microscopes; microscope bodies; microscope lamps; prisms for microscopes; reflectors for microscopes; lens barrels for microscopes in the nature of body tubes for microscopes; laboratory equipment, namely, microscope slides; containers for microscope slides; stands for operating microscopes; radiography and tomography apparatus and instruments other than for medical use, namely, optical scanners and optical coherence tomography machines, namely, a device using image projection technology that focuses light onto biological tissues to create afterimages for the user ] | ACTIVE | — |
| 010 | Measuring apparatus for medical and surgical use, namely, skin measuring apparatus; analysis apparatus for medical and surgical use, namely, apparatus for skin analysis; medical imaging apparatus; medical apparatus for diagnostic imaging, namely, nuclear medicine diagnostic imaging apparatus; medical imaging apparatus in the field of dermocosmetics; apparatus for the diagnosis of dermatological disorders; apparatus for the diagnosis of skin cancer; cell imaging and analysis devices for medical use, namely, cell imaging microscopes and imagers; examination lamps for medical use; probes for medical use; medical imaging screens, namely, medical imaging apparatus; computerized tomography apparatus, namely, x-ray CT scanners | ACTIVE | — |
| 042 | Services for design, development, updates and maintenance of software, applications and software platforms; services for design, development, updates and maintenance of computer algorithms; computer programming services in the medical field; computer program writing services for medical applications; design and development of software for use in the framework of medical technology; development of information technology systems and artificial intelligence computer systems for medical use; design and development of medical technologies; scientific research for medical purposes in the field of cancerous diseases; design and development of apparatus for medical diagnosis and monitoring; development and testing of computing methods, algorithms and software; design of computer database software; computer database design and development; maintenance of on-line databases for others; software as a service (SAAS) services featuring software for image analysis; software as a service (SAAS) services featuring software for use in medical imaging in the medical field; platform as a service (PAAS) services featuring computer software for image analysis; platform as a service (PAAS) services featuring computer software for medical diagnosis assistance in the medical field; quality evaluation of medical devices; quality control of medical devices for others; clinical research services in the field of medical imaging; medical research services in the field of medical imaging; testing, analysis and evaluation of medical devices of others for certification purposes; scientific advisory services relating to medical imaging; scientific research for medical purposes in the field of cancerous diseases; optics and physics research; computer system design for scientific and medical imaging; technical project study, namely, conducting scientific feasibility studies in the field of biomedical and cellular imaging; research and development of new products for others in the field of optics and molecular imaging; engineering services, namely, evaluations, assessments and research in the fields of science and technology provided by engineers; research and development of new products for others; technical project study, namely, conducting scientific feasibility studies in the field of medical imaging | ACTIVE | — |
| 044 | [Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; medical diagnosis services, namely, diagnosing skin diseases; medical evaluation services, namely, analyzing skin for purposes of determining and/or guiding treatment; medical assistance; medical consultations; medical analysis services for the diagnosis of cancer; telemedicine services; medical decision assistance and support services in the nature of medical diagnosis assistance provided by software and artificial intelligence; medical assistance services relating to health; medical consulting services in the field of medical devices; assessment and prevention services in the field of medicine and medical devices, namely, health assessment services; providing medical information with respect to medical devices] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DAMAE MEDICAL
- Other trademarks owned by DAMAE MEDICAL
- Other trademarks owned by DAMAE MEDICAL
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DAMAE MEDICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 7, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 7, 2026 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Jun 29, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 17, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 17, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 14, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 23, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 23, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 17, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 7, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 17, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 3, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 31, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 31, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 18, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 18, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 11, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 25, 2019 | ALIE | ASSIGNED TO LIE | — |
| Nov 21, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 8, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 8, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 8, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 8, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 24, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 24, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 24, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 24, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 23, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 23, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 23, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 23, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 20, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 19, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 19, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 12, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 22, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 22, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 13, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 12, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 5, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 5, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 28, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |